186 related articles for article (PubMed ID: 2459214)
1. Epitope mapping of HLA-B27 and HLA-B7 antigens by using intradomain recombinants.
Toubert A; Raffoux C; Boretto J; Sire J; Sodoyer R; Thurau SR; Amor B; Colombani J; Lemonnier FA; Jordan BR
J Immunol; 1988 Oct; 141(7):2503-9. PubMed ID: 2459214
[TBL] [Abstract][Full Text] [Related]
2. Delineation of determinants on HLA-B7 and HLA-B27 that are necessary for cytolytic T cell recognition by using inter- and intra-domain recombinants.
Healy F; Toubert A; Gomard E; Jordan BR; Levy JP
J Immunol; 1989 Oct; 143(7):2357-63. PubMed ID: 2476507
[TBL] [Abstract][Full Text] [Related]
3. Hybrid genes between HLA-A2 and HLA-A3 constructed by in vivo recombination allow mapping of HLA-A2 and HLA-A3 polymorphic antigenic determinants.
Sire J; Chimini G; Boretto J; Toubert A; Kahn-Perles B; Layet C; Sodoyer R; Lemonnier F; Jordan B
J Immunol; 1988 Apr; 140(7):2422-30. PubMed ID: 2450922
[TBL] [Abstract][Full Text] [Related]
4. In vitro mutagenesis of HLA-B27. Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain.
el-Zaatari FA; Sams KC; Taurog JD
J Immunol; 1990 Feb; 144(4):1512-7. PubMed ID: 1689355
[TBL] [Abstract][Full Text] [Related]
5. Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3.
Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
J Immunol; 1988 Oct; 141(7):2519-25. PubMed ID: 2459215
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of serologic recognition sites in the human HLA-A2 molecule.
Santos-Aguado J; Barbosa JA; Biro PA; Strominger JL
J Immunol; 1988 Oct; 141(8):2811-8. PubMed ID: 2459229
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T lymphocyte-defined epitope differences between HLA-A2.1 and HLA-A2.2 map to two distinct regions of the molecule.
Hogan KT; Clayberger C; Le AX; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
J Immunol; 1988 Dec; 141(11):4005-11. PubMed ID: 2460555
[TBL] [Abstract][Full Text] [Related]
8. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells.
Kurago ZB; Lutz CT; Smith KD; Colonna M
J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412
[TBL] [Abstract][Full Text] [Related]
9. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix.
Lutz CT; Smith KD; Greazel NS; Mace BE; Jensen DA; McCutcheon JA; Goeken NE
J Immunol; 1994 Nov; 153(9):4099-110. PubMed ID: 7523516
[TBL] [Abstract][Full Text] [Related]
10. Avidity dictates the lytic capacity of human cytolytic T lymphocyte clones with similar fine specificity against murine cells expressing HLA-B27 antigen.
Calvo V; Rojo S; Aparicio P; Galocha B; López de Castro JA
J Immunol; 1988 Dec; 141(11):3798-803. PubMed ID: 2460549
[TBL] [Abstract][Full Text] [Related]
11. The alpha 1/alpha 2 domains of class I HLA molecules confer resistance to natural killing.
Storkus WJ; Alexander J; Payne JA; Cresswell P; Dawson JR
J Immunol; 1989 Dec; 143(11):3853-7. PubMed ID: 2479694
[TBL] [Abstract][Full Text] [Related]
12. In vitro mutagenesis of HLA-B27. Substitution of an unpaired cysteine residue in the alpha 1 domain causes loss of antibody-defined epitopes.
Taurog JD; el-Zaatari FA
J Clin Invest; 1988 Sep; 82(3):987-92. PubMed ID: 2458390
[TBL] [Abstract][Full Text] [Related]
13. Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity.
Villadangos JA; Galocha B; López de Castro JA
J Immunol; 1994 Mar; 152(5):2317-23. PubMed ID: 7510742
[TBL] [Abstract][Full Text] [Related]
14. ME1 epitope of HLA-B27 confers class I-mediated modulation of gram-negative bacterial invasion.
Kapasi K; Inman RD
J Immunol; 1994 Jul; 153(2):833-40. PubMed ID: 7517424
[TBL] [Abstract][Full Text] [Related]
15. Clonal heterogeneity in LFA-3 and ICAM-1 requirement for lysis by alloreactive T lymphocytes.
Galocha B; López D; López de Castro JA
J Immunol; 1993 Mar; 150(5):1653-62. PubMed ID: 7679690
[TBL] [Abstract][Full Text] [Related]
16. Epitope mapping of human monoclonal antibodies to HLA-B27 by using natural and mutated antigenic variants.
Weyl D; Hansen T; Deschamps Y; Hannestad K; Toubert A
Hum Immunol; 1991 Aug; 31(4):271-6. PubMed ID: 1717416
[TBL] [Abstract][Full Text] [Related]
17. HLA (A*0201) mimicry by anti-idiotypic monoclonal antibodies.
Burlingham WJ; Jankowska-Gan E; DeVito-Haynes L; Fechner JH; Hogan KT; Claas FH; Mulder A; Wang X; Ferrone S
J Immunol; 1998 Dec; 161(12):6705-14. PubMed ID: 9862700
[TBL] [Abstract][Full Text] [Related]
18. NK cells from human MHC class I (HLA-B) transgenic mice do not mediate hybrid resistance killing against parental nontransgenic cells.
Kung SK; Su RC; Graham JJ; Chamberlain JW; Miller RG
J Immunol; 1998 Jan; 160(2):674-80. PubMed ID: 9551902
[TBL] [Abstract][Full Text] [Related]
19. Association with beta 2-microglobulin controls the expression of transfected human class I genes.
Rein RS; Seemann GH; Neefjes JJ; Hochstenbach FM; Stam NJ; Ploegh HL
J Immunol; 1987 Feb; 138(4):1178-83. PubMed ID: 3543123
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric HLA-B27 screening: cross-reactivity patterns of commercially available anti-HLA-B27 monoclonal antibodies with other HLA-B antigens.
Levering WH; Wind H; Sintnicolaas K; Hooijkaas H; Gratama JW
Cytometry B Clin Cytom; 2003 Jul; 54(1):28-38. PubMed ID: 12827665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
